Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
03/2006
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/29/2006EP1640361A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
03/29/2006EP1638924A1 Pesticidally active ketone and oxime derivatives
03/29/2006EP1638922A1 Pharmaceutically useful salts of carboxylic acid derivates
03/29/2006EP1638921A1 Pharmaceutically useful salts of carboxylic acid derivates
03/29/2006EP1638920A1 Processes for preparing (2s)-3-(4-{2-[amino]-2-oxo ethoxy}phenyl)-2-ethoxypropanoic acid derivatives
03/29/2006CN1753862A Therapeutic agents
03/29/2006CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
03/28/2006US7019030 Immunotherapeutic agents
03/28/2006US7018850 Luminescent lanthanide metal chelate for use as tool in diagnostic analysis
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006CA2580979A1 Novel compounds useful for modulating abnormal cell proliferation
03/22/2006CN1246467C Process for preparation of alkaline earth salts of D-pantothenic acid
03/22/2006CN1246300C Resorcinol derivatives
03/22/2006CN1246297C Synthesis of water soluble oxamonoamide
03/22/2006CN1246295C Method and intermediate used for manufacturing antifolic
03/22/2006CN1246287C Binaphthol derivative and method for producing same
03/22/2006CN1245936C Detergent composition containing new glycine derivative and its use
03/21/2006US7015346 Short-acting sedative hypnotic agents for anesthesia and sedation
03/21/2006US7015340 Heat-sensitive compounds exhibitng a cloud point which can be used as extractants for the separation of metals in aqueous solution
03/21/2006CA2186285C Carbonyl containing compounds and their derivatives as multi-functional fuel and lube additives
03/21/2006CA2124932C Sex steroid activity inhibitors
03/16/2006WO2006027680A1 3-(1-carbamoylcyclohexyl) propionic acid derivatives as inhibitors of neutral endopeptidase enzyme
03/16/2006WO2005095378A3 Vegetable based dioxanone derivatives, synthesis and uses thereof
03/16/2006US20060058554 e.g. 5-(4-Hydroxy-3-methoxyphenyl)-penta-2E,4E-dienoic acid benzylamide; tyrosine kinase inhibitor; antiproliferative agent; acute lymphoblastic leukaemia; modulating cell proliferation, diagnostic assays; minimal toxicity to normally growing cells and tissues
03/16/2006US20060058396 Amide compounds for the potentiation of cholinergic activity
03/16/2006US20060058389 Novel compounds that inhibit factor xa activity
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/15/2006EP1633190A1 Copper salts of organic acids and use thereof as fungicides
03/15/2006EP0997147B1 Amino acid derivatives
03/15/2006CN1245380C Anthranilic acid derivatives
03/14/2006US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
03/14/2006CA2180963C Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-.beta.-amino acids
03/09/2006WO2006024784A2 Aminoglycoside analogues, uses thereof for treating microbial diseases and synthesis thereof
03/09/2006WO2006024627A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
03/09/2006WO2006024587A1 Hydroxybenzoic acid amides and the use thereof for masking bitter taste
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006CA2576839A1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
03/08/2006EP1632470A2 Calcium receptor active molecules
03/08/2006EP1632236A1 Inhibitors of the anandamide transporter
03/08/2006EP1039902B1 Inhibitors of gap junction communication
03/07/2006US7009078 halogenating in the 5-position and hydroxylating in the 4-position under lactonization, replacing halogen with azide, amidating lactone, then transferring the azide to the amine group
03/07/2006US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
03/02/2006WO2006021759A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
03/02/2006WO2006000324A3 New mao-b inhibitors
03/02/2006WO2005120477A3 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
03/02/2006WO2005092305A3 Compounds for treating aids and other diseases
03/02/2006US20060047171 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof
03/02/2006CA2578721A1 Process for preparation of 4-fluoro-.alpha.-[2-methyl-1-oxopropyl].gamma.-oxo-n-.beta.-diphenylbenzene butane amide
03/02/2006CA2575200A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
03/01/2006CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
03/01/2006CN1740145A Cinnamide compound synthesizing process
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
03/01/2006CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
02/2006
02/28/2006USRE38995 Interfacial method of preparing ester-substituted diaryl carbonates
02/28/2006US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres.
02/23/2006US20060041169 Preparation of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
02/23/2006US20060041101 Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof
02/23/2006US20060041024 Polycationic compounds and uses thereof
02/23/2006US20060041014 Treatment of male sexual dysfunction
02/23/2006US20060040979 3-Aryl-2-hydroxypropionic acid derivative I
02/23/2006US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting
02/22/2006CN1736981A Selective androgen receptor modulators and methods of use thereof
02/22/2006CN1736980A Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
02/22/2006CN1736371A Selective androgen receptor modulators and methods of use thereof
02/22/2006CN1242983C Phenoxyacetic acid derivatives and medicinal compositions containing the same
02/21/2006US7001969 Methods of making intermediates from polyhydroxyalkanoates
02/21/2006CA2453080C Polyene polyketides, processes for their production and their use as a pharmaceutical
02/21/2006CA2251090C Phenylethanolaminotetralincarboxamide derivatives
02/16/2006WO2006016218A1 Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists
02/16/2006WO2005080317A3 Therapeutic amide derivatives
02/16/2006WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders
02/16/2006US20060035980 Thyronamine derivatives and analogs and methods of use thereof
02/16/2006US20060035979 Inhibitors of transcription factor NF-kappaB
02/15/2006EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders
02/15/2006EP1625111A2 Thyronamine derivatives and analogs and methods of use thereof
02/15/2006EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES
02/14/2006US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/14/2006CA2296237C Essentially colorless, transparent polyimide coatings and films
02/14/2006CA2189567C Substituted fused and bridged bicyclic compounds as therapeutic agents
02/09/2006US20060030565 Amide derivatives and nociceptin antagonists
02/09/2006US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma
02/09/2006US20060030553 Cell adhesion inhibitors
02/08/2006CN1732290A Hydrophobic-hydrophilic compounds for treating metallic surfaces
02/08/2006CN1732149A Process for the synthesis of 3.3a.6.6a-tetrahydro-2h-cyclopentan[b]furan-2-one
02/08/2006CN1732148A Process for preparing nitrile compound from olefinic unsaturated compound
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/08/2006CN1240679C 2- and 2,5-substituted phenylketoenols
02/07/2006US6995284 Synthesis of selective androgen receptor modulators
02/07/2006US6995230 Amorphous or liquid phenolic compounds having a carboxy group as stabilizers for processing molding plastics are controllably, uniformly dispersed and reproducible; nondiffusing; no bleeding-out; no surface deposits
02/07/2006US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006WO2006012227A2 Amido compounds and their use as pharmaceuticals
02/02/2006WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
02/02/2006WO2006010968A1 New aryloxy acetic acid amide derivatives
02/02/2006WO2006010718A1 Process for preparing solid particles of phenolic antioxidants
02/02/2006WO2006010598A1 Non-glycosidic and non-peptidic select inhibitors, and the use thereof
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 157